Loading institutional data...
Loading institutional data...
Held by 535 of 5,944 reporting institutions (97th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $60.85 today, the market must believe free cash flow compounds 23.7%/yr for a decade (off $154M normalized FCF).
The market's 23.7% is more optimistic than its 9-yr track record.
2-stage DCF · 0.17B shares · net debt -$263M
mean 11.7% · volatility σ 40% · implied rate exceeded in 4/9 yrs
Central path = implied 23.7%/yr growth; shaded band = ±1σ (40%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $994.4M 100.0% | $914.5M 100.0% | $837.5M 100.0% | $1.01B 100.0% | $1.04B 100.0% | $811.0M 100.0% | $725.6M 100.0% | $806.3M 100.0% | $766.1M 100.0% | $529.5M 100.0% |
| Cost of Revenue | $329.0M 33.1% | $288.7M 31.6% | $236.3M 28.2% | $284.2M 28.2% | $277.3M 26.7% | $206.4M 25.5% | $189.8M 26.2% | $206.1M 25.6% | $187.3M 24.4% | $131.1M 24.8% |
| Gross Profit | $665.4M 66.9% | $625.8M 68.4% | $601.2M 71.8% | $721.9M 71.8% | $759.8M 73.3% | $604.6M 74.5% | $535.9M 73.8% | $600.3M 74.4% | $578.8M 75.6% | $398.4M 75.2% |
| Research & Development | $139.0M 14.0% | $139.8M 15.3% | $139.4M 16.6% | $141.1M 14.0% | $135.4M 13.1% | $131.0M 16.2% | $119.4M 16.5% | $116.4M 14.4% | $99.2M 12.9% | $78.3M 14.8% |
| Selling, General & Admin | $363.9M 36.6% | $370.9M 40.6% | $339.1M 40.5% | $312.1M 31.0% | $309.4M 29.8% | $267.6M 33.0% | $273.8M 37.7% | $262.7M 32.6% | $220.7M 28.8% | $166.1M 31.4% |
| Operating Income | $162.6M 16.3% | $115.1M 12.6% | $130.7M 15.6% | $246.2M 24.5% | $315.1M 30.4% | $170.5M 21.0% | $142.6M 19.7% | $221.1M 27.4% | $258.9M 33.8% | $154.1M 29.1% |
| Other Income (Expense), net | $7.4M 0.7% | $922K 0.1% | $592K 0.1% | -$412K -0.0% | -$591K -0.1% | -$309K -0.0% | $1.2M 0.2% | -$219K -0.0% | -$338K -0.0% | $871K 0.2% |
| Pretax Income | $182.8M 18.4% | $131.5M 14.4% | $135.3M 16.2% | $250.7M 24.9% | $318.9M 30.7% | $186.9M 23.0% | $163.0M 22.5% | $234.6M 29.1% | $266.5M 34.8% | $162.1M 30.6% |
| Income Tax Expense | $68.4M 6.9% | $25.3M 2.8% | $22.1M 2.6% | $35.2M 3.5% | $39.0M 3.8% | $10.7M 1.3% | -$40.9M -5.6% | $15.3M 1.9% | $89.8M 11.7% | $18.1M 3.4% |
| Net Income | $114.4M 11.5% | $106.2M 11.6% | $113.2M 13.5% | $215.5M 21.4% | $279.9M 27.0% | $176.2M 21.7% | $203.9M 28.1% | $219.3M 27.2% | $176.7M 23.1% | $143.7M 27.1% |
| Per Share | ||||||||||
| EPS (Basic) | $0.68 | $0.62 | $0.66 | $1.24 | $1.59 | $1.02 | $1.19 | $1.27 | $1.02 | $0.84 |
| EPS (Diluted) | $0.68 | $0.62 | $0.65 | $1.23 | $1.56 | $1.00 | $1.16 | $1.24 | $0.98 | $0.83 |
| Weighted Avg Shares (Basic) | 168.0M | 171.4M | 172.2M | 173.4M | 176.5M | 173.5M | 171.2M | 172.3M | 173.3M | 170.7M |
| Weighted Avg Shares (Diluted) | 169.4M | 172.6M | 173.4M | 174.9M | 179.9M | 176.6M | 175.3M | 177.4M | 179.6M | 174.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
7/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 23% of free cash flow, leaving room to grow it and fund buybacks. Last year: $55M dividends + $151M buybacks = $206M returned on $237M FCF.
4 consecutive years of dividend increases · 1%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Modest payoff on reinvested capital. Current ROIC on all capital: 8%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 14-yr range · 84th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 4.7× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 25.6 | 26.2 | 25.5 | 26.7 | 28.2 | 28.2 | 31.6 | 33.1 |
| Gross Profit | 74.4 | 73.8 | 74.5 | 73.3 | 71.8 | 71.8 | 68.4 | 66.9 |
| R&D | 14.4 | 16.5 | 16.2 | 13.1 | 14.0 | 16.6 | 15.3 | 14.0 |
| SG&A | 32.6 | 37.7 | 33.0 | 29.8 | 31.0 | 40.5 | 40.6 | 36.6 |
| Operating Income | 27.4 | 19.7 | 21.0 | 30.4 | 24.5 | 15.6 | 12.6 | 16.3 |
| Income Tax | 1.9 | -5.6 | 1.3 | 3.8 | 3.5 | 2.6 | 2.8 | 6.9 |
| Net Income | 27.2 | 28.1 | 21.7 | 27.0 | 21.4 | 13.5 | 11.6 | 11.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CGNX: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 743 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TSM | $10.83T | — | — | — | — | — | — | — | — | — | 3,121 |
| NVDA | $5.20T | 43.6× | 39.0× | 24.1× | 65.5% | 71.1% | 55.6% | 76.3% | 72.4% | 0.1× | 5,582 |
| AAPL | $4.91T | 44.6× | 34.3× | 11.8× | 6.4% | 46.9% | 26.9% | 152% | 68.1% | 0.6× | 5,858 |
| MSFT | $3.64T | 27.3× | 19.3× | 11.0× | 17.8% | 67.9% | 40.3% | 30.2% | 27.7% | 0.2× | 5,944 |
| AVGO | $1.61T | 71.2× | 63.6× | 25.2× | 23.9% | 67.8% | 36.2% | 28.4% | 15.8% | 2.5× | 4,442 |
| MU | $1.04T | 122.1× | 57.5× | 27.8× | 48.9% | 39.8% | 22.8% | 15.8% | 12.9% | 0.7× | 2,894 |
| AMD | $835.4B | 193.4× | 197.6× | 24.1× | 34.3% | 49.5% | 12.5% | 6.9% | 6.5% | 0.8× | 3,059 |
| INTC | $504.6B | — | 62.9× | 9.6× | -0.5% | 34.8% | -0.5% | -0.2% | -0.2% | 5.5× | 2,495 |
| CSCO | $426.7B | 42.3× | 35.8× | 7.5× | 5.3% | 64.9% | 18.0% | 21.7% | 13.6% | 2.3× | 3,560 |
| PLTR | $416.9B | 276.7× | 288.5× | 93.2× | 56.2% | 82.4% | 36.3% | 22.0% | 22.0% | — | 2,883 |
| DELL | $367.3B | 64.9× | 34.6× | 3.2× | 18.8% | 20.0% | 5.2% | -240% | 20.4% | 2.8× | 1,564 |
| LRCX | $341.6B | 64.9× | 54.5× | 18.5× | 23.7% | 48.7% | 29.1% | 54.3% | 37.4% | 0.7× | 2,500 |
| AMAT | $329.4B | 48.0× | 37.9× | 11.6× | 4.4% | 48.7% | 24.7% | 34.3% | 25.9% | 0.8× | 2,826 |
| RPAY | $325.1B | — | — | 1051.3× | -1.2% | 75.0% | -83.0% | -53.0% | -28.2% | -1.7× | 142 |
| UMC | $283.0B | — | — | — | — | — | — | — | — | — | 302 |
| SAP | $261.9B | — | — | — | — | — | — | — | — | — | 794 |
| ARM | $259.6B | 287.0× | 223.6× | 52.8× | 22.8% | 97.5% | 18.4% | 10.9% | 10.9% | — | 730 |
| PANW | $250.9B | 234.8× | 156.8× | 27.2× | 14.9% | 73.4% | 12.3% | 14.5% | 14.5% | — | 2,374 |
| ANET | $248.2B | 71.8× | 62.7× | 27.6× | 28.6% | 64.1% | 39.0% | 28.4% | 28.4% | — | 1,930 |
| TXN | $236.9B | 47.8× | 31.2× | 13.4× | 13.0% | 57.0% | 28.3% | 30.7% | 16.5% | 1.8× | 2,345 |
| CRM | $232.8B | 32.1× | 25.2× | 5.6× | 9.6% | 77.7% | 18.0% | 12.6% | 10.1% | 1.5× | 2,547 |
| IBM | $222.5B | 21.3× | — | 3.3× | 7.6% | 58.2% | 15.7% | 32.4% | 11.3% | — | 3,351 |
| SNDK | $221.9B | — | — | 30.2× | 10.4% | 30.1% | -22.3% | -17.8% | -14.8% | -1.5× | 1,127 |
| QCOM | $198.5B | 36.9× | 14.9× | 4.5× | 13.7% | 55.4% | 12.5% | 26.1% | 15.4% | 1.1× | 2,611 |
| MRVL | $194.6B | 74.8× | 127.2× | 23.8× | 42.1% | 51.0% | 32.6% | 18.7% | 14.2% | 2.9× | 1,477 |
| CGNX | $10.0B | 88.4× | 53.5× | 10.1× | 8.7% | 66.9% | 11.5% | 7.7% | 7.7% | — | 535 |
Peers = companies sharing CGNX's sector (Technology) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.